These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23205309)

  • 1. Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience.
    Malik NK; May KS; Chandrasekhar R; Wee W; Flaherty L; Iyer R; Gibbs J; Kuvshinoff B; Wilding G; Warren G; Yang GY
    J Gastrointest Oncol; 2012 Dec; 3(4):326-34. PubMed ID: 23205309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated intensity-modulated radiotherapy with concurrent chemotherapy for elderly patients with locally advanced pancreatic carcinoma.
    Iwai T; Yoshimura M; Ashida R; Goto Y; Kishi T; Itasaka S; Shibuya K; Kanai M; Masui T; Fukuda A; Isoda H; Hiraoka M; Mizowaki T
    Radiat Oncol; 2020 Nov; 15(1):264. PubMed ID: 33187523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer.
    Chadha AS; Kocak-Uzel E; Das P; Minsky BD; Delclos ME; Mahmood U; Guha S; Ahmad M; Varadhachary GR; Javle M; Katz MH; Fleming JB; Wolff RA; Crane CH; Krishnan S
    Acta Oncol; 2015 Jul; 54(7):971-8. PubMed ID: 25608822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer.
    Yang GY; Malik NK; Chandrasekhar R; Ma WW; Flaherty L; Iyer R; Kuvshinoff B; Gibbs J; Wilding G; Warren G; May KS
    J Gastrointest Oncol; 2013 Dec; 4(4):361-9. PubMed ID: 24294507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study.
    Choi Y; Oh DY; Kim K; Chie EK; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Ha SW; Bang YJ
    Cancer Res Treat; 2016 Jul; 48(3):1045-55. PubMed ID: 26511805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontrial, real-world outcomes in unresectable locally advanced pancreatic cancer: Chemotherapy and chemoradiation is the standard while surgery is uncommon.
    Ramaswamy A; Jandyal S; Ostwal V; Engineer R; Lewis S; Bose S; Pande N; Shrikhande SV
    Indian J Cancer; 2017; 54(3):530-534. PubMed ID: 29798952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Cancer.
    Takada R; Ikezawa K; Daiku K; Maeda S; Abe Y; Urabe M; Kai Y; Yamai T; Fukutake N; Nakabori T; Uehara H; Ashida R; Akita H; Takahashi H; Teshima T; Ohkawa K
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiagent induction chemotherapy followed by chemoradiation is associated with improved survival in locally advanced pancreatic cancer.
    Torgeson A; Lloyd S; Boothe D; Tao R; Whisenant J; Garrido-Laguna I; Cannon GM
    Cancer; 2017 Oct; 123(19):3816-3824. PubMed ID: 28621885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer.
    Kwak YK; Lee JH; Lee MA; Chun HG; Kim DG; You YK; Hong TH; Jang HS
    Radiat Oncol J; 2014 Jun; 32(2):49-56. PubMed ID: 25061572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Rates of Concurrent Chemo-Radiation versus Radiation Alone in Locally Advanced, Unresectable Head and Neck Cancers: A Retrospective Cohort Study.
    Eursritanakorn S
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S91-8. PubMed ID: 27266222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single institutional experience of combined carbon-ion radiotherapy and chemotherapy for unresectable locally advanced pancreatic cancer.
    Shinoto M; Terashima K; Suefuji H; Matsunobu A; Toyama S; Fukunishi K; Shioyama Y
    Radiother Oncol; 2018 Nov; 129(2):333-339. PubMed ID: 30224179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated.
    Chuong MD; Springett GM; Freilich JM; Park CK; Weber JM; Mellon EA; Hodul PJ; Malafa MP; Meredith KL; Hoffe SE; Shridhar R
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):516-22. PubMed ID: 23562768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation.
    Krishnan S; Chadha AS; Suh Y; Chen HC; Rao A; Das P; Minsky BD; Mahmood U; Delclos ME; Sawakuchi GO; Beddar S; Katz MH; Fleming JB; Javle MM; Varadhachary GR; Wolff RA; Crane CH
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):755-65. PubMed ID: 26972648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiation therapy for locally advanced pancreatic cancer.
    Jung J; Yoon SM; Park JH; Seo DW; Lee SS; Kim MH; Lee SK; Park DH; Song TJ; Ryoo BY; Chang HM; Kim KP; Yoo C; Jeong JH; Kim SC; Hwang DW; Lee JH; Song KB; Jo YY; Park J; Kim JH
    PLoS One; 2019; 14(4):e0214970. PubMed ID: 30978229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent chemoradiation in locally advanced head and neck cancers: a comparative study of weekly Paclitaxel versus Cisplatin-based regimen.
    Essa HH; Azzam M
    J Egypt Natl Canc Inst; 2010 Sep; 22(3):165-73. PubMed ID: 21863067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck.
    Suntharalingam M; Haas ML; Van Echo DA; Haddad R; Jacobs MC; Levy S; Gray WC; Ord RA; Conley BA
    Cancer; 2001 Feb; 91(3):548-54. PubMed ID: 11169937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study.
    Suker M; Nuyttens JJ; Groot Koerkamp B; Eskens FALM; van Eijck CHJ
    J Surg Oncol; 2018 Nov; 118(6):1021-1026. PubMed ID: 30259526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.